Clinical Trial Update: Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Malignant Tumor [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating a Gallium-68 labeled CD73-targeting PET/CT imaging probe for diagnosing malignant tumors. The trial is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• 68Ga-labeled CD73-targeting imaging probe (Gallium-68 labeled CD73-targeting PET imaging probe)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Tumor Immunity | NA | Status: RECRUITING